In the Media

Viewing records where tag name contains "media" View All

AGM Chairman’s address and CEO’s presentation (ASX Announcement)

Nov 30th, 2021

Attached is the Chairman’s address together with the CEO’s presentation to the Annual General Meeting (AGM) of Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY), to be held at 11am (Melbourne time) today.

Read More

Starpharma (ASX:SPL) continues VIRALEZE success in December quarter

Oct 29th, 2021

"Starpharma (SPL) has released its September quarterly report, with the quarter again highlighted by the continued success of VIRALEZE," as reported by The Market Herald. 

Read More

Starpharma signs distribution agreement for antiviral in Vietnam

Oct 26th, 2021

News of Starpharma signing an initial supply contract for VIRALEZE™ in Vietnam featured in BiotechDispatch. Read the article here

Read More

Starpharma (ASX:SPL) signs VIRALEZE supply deal for Vietnam

Oct 26th, 2021

The Market Herald features news of Starpharma's latest supply arrangement for VIRALEZE™ in Vietnam.

Read More

Nanotechnology Offers New Ways To Fight An Endless Pandemic

Oct 18th, 2021

Starpharma's VIRALEZE™ antiviral nasal spray was featured in Report Wire.

Read More

Nanotechnology offers alternative ways to fight COVID-19 pandemic with antivirals

Oct 14th, 2021

Starpharma's VIRALEZE™ antiviral nasal spray was featured in the October issue (VOL 39) of Nature Biotechnology

Read More

Starpharma (ASX:SPL) launches nasal spray into Italian market

Oct 8th, 2021

The Market Herald features news of Starpharma's latest distribution agreement for VIRALEZE™ antiviral nasal spray in Italy. 

Read More

Starpharma (ASX:SPL) shows 99.99pc antiviral activity against Delta COVID-19 variant

Jul 27th, 2021

"Starpharma's (SPL) SPL7013 drug has shown a reduction of more than 99.99 per cent against the Delta variant of SARS-CoV-2," The Market Herald reports. Read the full article here.  Read More

COVID-19: Viraleze Nasal Spray Highly Effective Against Alpha, Beta And Gamma Variants

Jun 19th, 2021

"New data released on June 18 showed that Australia’s Viraleze anti-COVID nasal spray is more than 99.99 per cent effective against three of the four variants of the SARS-CoV-2 virus," as reported by Republic World. Read the full article here.

Read More

Latest Testing Confirms Viraleze Highly Effective Against Alpha, Beta and Gamma COVID Variants

Jun 18th, 2021

News18 reports on Starpharma's latest VIRALEZETM announcement: "New data released today shows that Australia’s Viraleze anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus." Read the full article here.

Read More

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

Jun 18th, 2021

Markets Insider features Starpharma's latest announcement, ..."The results hold significant promise for Viraleze™ – developed by Melbourne-based biopharmaceutical company Starpharma (ASX: SPL) – in the fight against new and emerging variants of SARS-CoV-2, as several countries begin their long-awaited opening of international borders..." Read the full article here

Read More

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

Jun 18th, 2021

"New data released today shows that Australia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus," as reported by the New Delhi Times. Read the full article here.

Read More

Starpharma (ASX:SPL) shows 99.9pc antiviral activity against three COVID-19 variants

Jun 18th, 2021

"Starpharma's (SPL) SPL7013 drug has shown a reduction of more than 99.9 per cent against the Alpha, Beta and Gamma SARS-CoV-2 variants," The Market Herald reports. Read the full article here.

Read More

Scripps Research Institute testing shows Viraleze highly active against UK COVID strain

Jun 1st, 2021

Markets Insider featured Viraleze and Starpharma following the announcement of SPL7013's potent antiviral activity against the UK coronavirus variant. Read the full article here

Read More

Starpharma (ASX:SPL)'s nasal spray achieves 98% efficacy against COVID-19

Jun 1st, 2021

"Biopharmaceutical company Starpharma (ASX:SPL) claims the company’s nasal spray product is a highly efficacious means of protection from the UK variant of the coronavirus," Finance News Network reports. Read the full article here

Read More

Starpharma (ASX:SPL) shows 98pc antiviral activity against U.K COVID-19 variant

Jun 1st, 2021

The Market Herald reports on Starpharma's latest announcement: "Starpharma (SPL) has confirmed that its SPL7013 drug has potent antiviral activity against the U.K. SARS-CoV-2 variant.

"In laboratory studies, SPL7013 achieved a reduction of more than 98 per cent against the virus."

Read the full article here. 

Read More

Tackling Covid: How the Harlequins are defending themselves

May 22nd, 2021

Twickenham Nub News interviewed Harlequins’ Head of Medical Services, Mike Lancaster, about the partnership with Viraleze. "The Harlequins’ long-awaited return to Twickenham Stoop has seen the team make many changes to ensure players’ safety.

"Alongside several changes at the stadium, the team has also started defending itself with a new nose spray, Viraleze." Read the full article here. 

Read More

Tax incentives to encourage innovation

May 18th, 2021

Dr Jackie Fairley, CEO of Starpharma discusses the Australian governments proposals for a 'patent box' and what it will mean for the company and Australian innovation in general. Watch here. (ausbiz account required)

Read More

Harlequins Partners with Anti-Viral Nasal Spray Viraleze

May 11th, 2021

Sport Industry Group featured the announcement of Starpharma's VIRALEZETM partnership with Harlequins. "Harlequins has announced a new partnership with antiviral nasal spray VIRALEZETM, which the club says it will use as one part of its suite of measures put in place to help protect its players and coaching staff." Read more here.

Read More

Harlequins Partners Antiviral Nasal Spray Brand Viraleze

May 11th, 2021

iSportconnect reported on the new partnership between Starpharma's antiviral nasal spray, VIRALEZETM, and Harlequins, a professional rugby union team in the UK. Read more here

Read More